Rolf Ljung
81 – 90 of 259
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Novel coagulation factor concentrates: Issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients.
- Contribution to journal › Scientific review
-
Mark
Factor VIII Products and Inhibitor Development in Severe Hemophilia A
- Contribution to journal › Article
-
Mark
Intermediate- dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s
- Contribution to journal › Article
- 2012
-
Mark
Investigation of disease-associated factors in haemophilia A patients without detectable mutations.
- Contribution to journal › Article
-
Mark
Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.
- Contribution to journal › Article
-
Mark
An MRI scale for assessment of haemophilic arthropathy from the International Prophylaxis Study Group.
- Contribution to journal › Article
-
Mark
How to manage invasive procedures in children with haemophilia.
- Contribution to journal › Article
-
Mark
Beyond patient benefit: clinical development in hemophilia
- Contribution to journal › Scientific review
-
Mark
Origin of Swedish hemophilia A mutations
- Contribution to journal › Article
-
Mark
Haemophilia Care in Europe: the ESCHQoL study
- Contribution to journal › Article
